The spectrum of exercise tolerance in mitochondrial myopathies: A study of 40 patients

Brain

Volumn 126, Issue 2, 2003, Pages 413-423

  Taivassalo, Tanja ^a   Jensen, Tina Dysgaard ^e   Kennaway, Nancy ^c   DiMauro, Salvatore ^d   Vissing, John ^e   Haller, Ronald G ^a,b,f  

^a PRESBYTERIAN HOSPITAL OF DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d Columbia Univ Coll of Phys/Surg ^*  (United States)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f IEEM   (United States)

Author keywords

Exercise; Mitochondrial myopathies; Oxidative metabolism

Indexed keywords

MITOCHONDRIAL DNA;

ADOLESCENT; ADULT; AEROBIC METABOLISM; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EXERCISE TOLERANCE; FEMALE; GENE MUTATION; HEART OUTPUT; HUMAN; LUNG VENTILATION; MALE; MITOCHONDRIAL MYOPATHY; MITOCHONDRIAL RESPIRATION; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; WORK CAPACITY;

EID: 0037314931     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awg028     Document Type: Article

References (37)

1. Andreu AL, Hanna MG, Reichmann H, Bruno C, Penn AS, Tanji K, et al. Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. N Engl J Med 1999a; 341: 1037-44.
2. Andreu AL, Tanji K, Bruno C, Hadjigeorgiou GM, Sue CM, Jay C, et al. Exercise intolerance due to a nonsense mutation in the mtDNA ND4 gene. Ann Neurol 1999b; 45: 820-3.
3. Anitori RP, Quan F, Buist NRM, Shoubridge EA, Kennaway, NG. A novel mutation in the mitochondrial tRNATrp gene in a sporadic case of mitochondrial myopathy [abstract]. In: Proceedings of the 4th European Meeting on Mitochondrial Pathology. Cambridge: Blackwell Scientific Publishing; 1999. p. 73.
4. Bank W, Chance B. An oxidative defect in metabolic myopathies: diagnosis by noninvasive tissue oximetry. Ann Neurol 1994; 36: 830-7.
5. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14: 377-81.
6. Carroll JE, Hagberg JM, Brooke MH, Shumate JB. Bicycle ergometry and gas exchange measurements in neuromuscular diseases. Arch Neurol 1979; 36: 457-61.
7. Chinnery PF, Howell N, Lightowlers RN, Tumbull DM. Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes. Brain 1997; 120: 1713-21.
8. Chinnery PF, Taylor DJ, Brown DT, Manners D, Styles P, Lodi R. Very low levels of the mtDNA A3243G mutation associated with mitochondrial dysfunction in vivo. Ann Neurol 2000; 47: 381-4.
9. Chinnery PF, Taylor DJ, Manners D, Styles P, Lodi R. No correlation between muscle A3243G mutation load and mitochondrial function in vivo. Neurology 2001; 56: 1101-4.
10. Chomyn A, Lai ST, Shakeley R, Bresolin N, Scarlato G, Attardi G. Platelet-mediated transformation of mtDNA-less human cells: analysis of phenotypic variability among clones from normal individuals - and complementation behavior of the tRNALys mutation causing myoclonic epilepsy and ragged red fibers. Am J Hum Genet 1994; 54: 966-74.
11. DiMauro S. Exercise intolerance and the mitochondrial respiratory chain. [Review]. Ital J Neurol Sci 1999; 20: 387-93.
12. Elliot DL, Buist NR, Goldberg L, Kennaway NG, Powell BR, Kuehl KS. Metabolic myopathies: evaluation by graded exercise testing. Medicine (Baltimore) 1989; 68: 163-72.
13. Faulkner JA, Heigenhauser GJ, Schork MA. The cardiac output-oxygen uptake relationship of men during graded bicycle ergometry. Med Sci Sports 1977; 9: 148-54.
14. Flaherty KR, Wald J, Weisman IM, Zeballos RJ, Schork MA, Blaivas M, et al. Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy. Am J Respir Crit Care Med 2001; 164: 425-32.
15. Haller RG, Bertocci LA. Exercise evaluation of metabolic myopathies. In: Engel AG, Franzini-Armstrong C, editors. Myology. 2nd edn. New York: McGraw-Hill: 1994. p. 807-21.
16. Haller RG, Vissing J. Circulatory regulation in muscle disease. In: Saltin B, Bouschel R, Secher N, Mitchell J, editors. Exercise and circulation in health and disease. Champaigne (IL): Human Kinetics; 2000. p. 263-73.
17. Haller RG, Lewis SF, Cook JD, Blomqvist CG. Hyperkinetic circulation during exercise in neuromuscular disease. Neurology. 1983; 33: 1283-7.
18. Haller RG, Lewis SF, Estabrook RW, DiMauro S, Servidei S, Foster DW. Exercise intolerance, lactic acidosis, and abnormal cardiopulmonary regulation in exercise 'associated with adult skeletal muscle cytochrome c oxidase deficiency. J Clin Invest 1989; 84: 155-161.
19. Haller RG, Henriksson KG, Jorfeldt L, Hultman E, Wibom R, Sahlin K, et al. Deficiency of skeletal muscle succinate dehydrogenase and aconitase. Pathophysiology of exercise in a novel human muscle oxidative defect. J Clin Invest 1991; 88: 1197-206.
20. Hammans SR, Sweeney MG, Hanna MG, Brockington M, Morgan-Hughes JA, Harding AE. The mitochondrial DNA transfer RNALeu(UUR) A→G(3243) mutation. A clinical and genetic study. Brain 1995; 118: 721-34.
21. Hedges LV, Olkin I. Procedure to identify outliers in regression models. In: Statistical methods for meta-analysis. New York: Harcourt Brace Jovanovich Publishers; 1985. p. 248-61.
22. Karadimas CL, Greenstein P, Sue CM, Joseph JT, Tanji K, Haller RG, et al. Recurrent myoglobinuria due to a nonsense mutation in the COX I gene of mitochondrial DNA. Neurology 2000; 55: 644-9.
23. Keightley JA, Hoffbuhr KC, Burton MD, Salas VM, Johnston WS, Penn AM, et al. A microdeletion in cytochrome c oxidase (COX) subunit III associated with COX deficiency and recurrent myoglobinuria. Nature Genet 1996; 12: 410-6.
24. Mitchell JH, Blomqvist G. Maximal oxygen uptake. N Engl J Med 1971; 6: 1018-22.
25. Morgan-Hughes JA, Hanna MG. Mitochondrial encephalomyopathies: the enigma of genotype versus phenotype. [Review]. Biochim Biophys Acta 1999; 1410: 125-45.
26. Pulkes T, Siddiqui A, Morgan-Hughes JA, Hanna MG. A novel mutation in the mitochondrial tRNA(Tyr) gene associated with exercise intolerance. Neurology 2000; 55: 1210-12.
27. Schwartz M, Vissing J. Paternal inheritance of mitchondrial DNA in man. N Engl J Med 2002; 347: 576-80.
28. Sobreira C, Hirano M, Shanske S, Keller K, Haller RG, Davidson E, et al. Mitochondrial encephalomyopathy with coenzyme Q10 deficiency. Neurology 1997; 48: 1238-43.
29. Taivassalo T, Shoubridge EA, Chen J, Kennaway NG, DiMauro S, Arnold DA, et al. Aerobic conditioning in patients with mitochondrial myopathies: physiological, biochemical and genetic effects. Ann Neurol 2001; 50: 133-41.
30. Taivassalo T, Abbott A, Wyrick P, Haller RG. Venous oxygen levels during aerobic forearm exercise: an index of impaired oxidative metabolism in mitochondrial myopathy. Ann Neurol 2002; 51: 38-44.
31. Triebwasser JH, Johnson RL, Burpo RP, Campbell JC, Reardon WC, Blomqvist CG. Noninvasive determination of cardiac output by a modified acetylene rebreathing procedure utilizing mass spectrometer measurements. Aviat Space Environ Med 1977; 48: 203-9.
32. Vissing J, Galbo H, Haller RG. Exercise fuel mobilization in mitochondrial myopathy: a metabolic dilemma. Ann Neurol 1996; 40: 655-62.
33. Met gene mutation in a patient with dystrophic muscle and exercise intolerance. Neurology 1998; 50: 1875-8.
34. Vissing J, Gansted U, Quistorff B. Exercise intolerance in mitochondrial myopathy is not related to lactic acidosis. Ann Neurol 2001; 49: 672-6.
35. Wariar R, Gaffke JN, Haller RG, Bertocci LA. A modular system for clinical measurement of impaired skeletal muscle oxygenation. J Appl Physiol 2000; 88: 315-25.
36. Wasserman K. Normal values. In: Wasserman K. Principles of exercise testing and interpretation. Philadelphia: Lea & Febiger; 1986. p. 72-86.
37. Wasserman K, Whipp BJ. Excercise physiology in health and disease. Am Rev Resp Dis 1975; 112: 219-49.